Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of 177Lu-PSMA-0057 in Metastatic Prostate Cancer

NCT06050239 is registered in ClinicalTrials.gov with Nanjing First Hospital, Nanjing Medical University as lead sponsor.

NCT NCT06050239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06050239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of 177Lu-PSMA-0057 in Metastatic Prostate Cancer
Lead sponsor
Nanjing First Hospital, Nanjing Medical University
Phase
Phase 1
Overall status
Unknown status
Start date
March 1, 2023
Completion date
March 1, 2025
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate cancer